- Home
- RNW vs HCM Comparison
RNW vs HCM Comparison
Compare RNW & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNW
- HCM
- Stock Information
- Founded
- RNW 2011
- HCM 2000
- Country
- RNW United Kingdom
- HCM Hong Kong
- Employees
- RNW N/A
- HCM N/A
- Industry
- RNW Electric Utilities: Central
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- RNW Utilities
- HCM Health Care
- Exchange
- RNW Nasdaq
- HCM Nasdaq
- Market Cap
- RNW 2.2B
- HCM 2.6B
- IPO Year
- RNW N/A
- HCM N/A
- Fundamental
- Price
- RNW $6.01
- HCM $15.25
- Analyst Decision
- RNW Strong Buy
- HCM Hold
- Analyst Count
- RNW 1
- HCM 1
- Target Price
- RNW $7.50
- HCM $19.00
- AVG Volume (30 Days)
- RNW 839.3K
- HCM 85.0K
- Earning Date
- RNW 02-18-2025
- HCM 03-19-2025
- Dividend Yield
- RNW N/A
- HCM N/A
- EPS Growth
- RNW N/A
- HCM N/A
- EPS
- RNW 0.04
- HCM 0.04
- Revenue
- RNW $1,006,524,942.00
- HCM $630,201,000.00
- Revenue This Year
- RNW N/A
- HCM $28.98
- Revenue Next Year
- RNW $38.75
- HCM $20.41
- P/E Ratio
- RNW $153.19
- HCM $69.52
- Revenue Growth
- RNW N/A
- HCM N/A
- 52 Week Low
- RNW $5.15
- HCM $12.84
- 52 Week High
- RNW $7.49
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- RNW 40.25
- HCM 50.03
- Support Level
- RNW $6.09
- HCM $14.00
- Resistance Level
- RNW $6.29
- HCM $16.64
- Average True Range (ATR)
- RNW 0.16
- HCM 0.47
- MACD
- RNW 0.01
- HCM -0.12
- Stochastic Oscillator
- RNW 47.01
- HCM 47.35
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.